Hoth Therapeutics (HOTH) announced advancements in its intellectual property portfolio through the acquisition and expansion of patent applications to its therapeutic pipeline.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOTH:
- Biotech Alert: Searches spiking for these stocks today
- 3 Penny Stocks to Watch Now, 1/9/25
- Hoth Therapeutics responds to market rumors, says no plans for offering
- Hoth Therapeutics affirms no plans for public, private offering at this time
- Hoth Therapeutics: Strong balance sheet includes over $10M cash, no debt